Tumor Biology

, Volume 35, Issue 7, pp 6955–6960 | Cite as

MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells

  • Hong-Lei Jiang
  • Hao Yu
  • Xu Ma
  • Dong Xu
  • Guo-Fu Lin
  • Dong-Yan Ma
  • Jun-Zhe JinEmail author
Research Article


Multiple studies have shown that steroid receptor coactivator-3 (SRC-3) is upregulated and promotes cell proliferation in several human cancers, including breast, lung, and prostate carcinoma. However, its molecular determinants remain largely unexplored. In the current study, by way of informatics software, we found that MicroRNA-195 (miR-195) could negatively regulate protein levels of SRC-3 through targeting its 3′-untranslated region (3′-UTR) in hepatocellular carcinoma (HCC) cells. As a result, miR-195 mimics inhibited while its antisense enhanced SRC-3 protein levels. Furthermore, miR-195 could modulate cell proliferation and tumor growth in vivo and in vitro. Therefore, our results demonstrate a novel molecular mechanism for the dysregulated expression of SRC-3 in hepatocellular carcinoma.


SRC-3 miR-195 Hepatocellular carcinoma Proliferation 



This work was supported by the Science and Technology Program of LiaoNing (2012225019).

Conflicts of interest


Supplementary material

13277_2014_1933_MOESM1_ESM.tif (217 kb)
Supplementary Fig. 1 (a-b) Western blot analysis of SRC-3 expression in HepG2 cells with or without transfection of miR-195 mimics (a), antisense (b) or negative control (NC). (TIFF 216 kb)
13277_2014_1933_MOESM2_ESM.tif (137 kb)
Supplementary Fig. 2 (a-b) Western blot analysis of SRC-3 expression in HuH7 cells transfected with miR-195 mimics (a), antisense (b) or negative control (NC). (TIFF 137 kb)


  1. 1.
    York B, O'Malley BW. Steroid receptor coactivator (src) family: Masters of systems biology. J Biol Chem. 2010;285:38743–50.PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol (Baltimore, Md). 2003;17:1681–92.CrossRefGoogle Scholar
  3. 3.
    Liao L, Kuang SQ, Yuan Y, Gonzalez SM, O'Malley BW, Xu J. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J Steroid Biochem Mol Biol. 2002;83:3–14.CrossRefPubMedGoogle Scholar
  4. 4.
    Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley BW. The steroid receptor coactivator src-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci U S A. 2000;97:6379–84.PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Louet JF, Coste A, Amazit L, Tannour-Louet M, Wu RC, Tsai SY, et al. Oncogenic steroid receptor coactivator-3 is a key regulator of the white adipogenic program. Proc Natl Acad Sci U S A. 2006;103:17868–73.PubMedCentralCrossRefPubMedGoogle Scholar
  6. 6.
    Coste A, Louet JF, Lagouge M, Lerin C, Antal MC, Meziane H, et al. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}. Proc Natl Acad Sci U S A. 2008;105:17187–92.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Tien JC, Xu J. Steroid receptor coactivator-3 as a potential molecular target for cancer therapy. Expert Opin Ther Targets. 2012;16:1085–96.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Ma G, Ren Y, Wang K, He J. SRC-3 has a role in cancer other than as a nuclear receptor coactivator. Int J Biol Sci. 2011;7:664–72.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Lydon JP, O'Malley BW. Minireview: Steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis. Endocrinology. 2011;152:19–25.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Ling H, Fabbri M, Calin GA. Micrornas and other non-coding rnas as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12:847–65.CrossRefPubMedGoogle Scholar
  11. 11.
    Sun K, Lai EC. Adult-specific functions of animal micrornas. Nat Rev Genet. 2013;14:535–48.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Gougelet A, Colnot S. [microrna: new diagnostic and therapeutic tools in liver disease?]. Medecine Sciences. 2013;29:861–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M. Role of micrornas in hepatocellular carcinoma: A clinical perspective. OncoTargets and Therapy. 2013;6:1167–78.PubMedCentralPubMedGoogle Scholar
  14. 14.
    Karmakar S, Gao T, Pace MC, Oesterreich S, Smith CL. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor. Mol Endocrinol. 2010;24:1187–202.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, Zhuang SM. Microrna-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology (Baltimore, Md). 2009;50:113–21.CrossRefGoogle Scholar
  16. 16.
    Yang X, Yu J, Yin J, Xiang Q, Tang H, Lei X. Mir-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2. Die Pharmazie. 2012;67:645–51.PubMedGoogle Scholar
  17. 17.
    Mussi P, Yu C, O'Malley BW, Xu J. Stimulation of steroid receptor coactivator-3 (src-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3. Mol Endocrinol (Baltimore, Md). 2006;20:3105–19.CrossRefGoogle Scholar
  18. 18.
    Garabedian MJ, Logan SK. Atypical regulation of SRC-3. Trends Biochem Sci. 2008;33:301–4.CrossRefPubMedGoogle Scholar
  19. 19.
    Yi P, Feng Q, Amazit L, Lonard DM, Tsai SY, Tsai MJ, et al. Atypical protein kinase c regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1. Mol Cell. 2008;29:465–76.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Long W, Foulds CE, Qin J, Liu J, Ding C, Lonard DM, et al. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J Clin Invest. 2012;122:1869–80.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Hong-Lei Jiang
    • 1
  • Hao Yu
    • 1
  • Xu Ma
    • 1
  • Dong Xu
    • 1
  • Guo-Fu Lin
    • 1
  • Dong-Yan Ma
    • 1
  • Jun-Zhe Jin
    • 1
    Email author
  1. 1.The Fourth Affiliated Hospital of China Medical UniversityShenyangChina

Personalised recommendations